I'd bet even buying at the 2nd most expensive OECD nations price would make a huge dent and seems more than reasonable for all the tax breaks and other incentiv

I'd bet even buying at the 2nd most expensive OECD nations price would make a huge dent and seems more than reasonable for all the tax breaks and other incentives pharmacal companies receive.